» Articles » PMID: 9014198

Contribution of Human Cytochrome P450 to Benzo[a]pyrene and Benzo[a]pyrene-7,8-dihydrodiol Metabolism, As Predicted from Heterologous Expression in Yeast

Overview
Specialties Genetics
Pharmacology
Date 1996 Dec 1
PMID 9014198
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The metabolism of benzo[a]pyrene (B[a]P) and its proximate mutagen B[a]P-7,8-dihydrodiol (7,8-diol) was investigated in the presence of human microsomal epoxide hydrolase and P450 1A1, 1A2, 2C8, 2C9, 2C18, 2C19, 2D6 and 3A4 expressed in the yeast Saccharomyces cerevisiae. P450 1A1 had the highest turnover numbers for the formation of all B[a]P metabolites, including phenols and dihydrodiols. P450 1A2, 2C8, 2C9, 2C18, 2C19 and 3A4, which are well represented in the liver, gave rise to the formation of appreciable amounts of 3-hydroxy-B[a]P and of some dihydrodiols from B[a]P. When 7,8-diol was used as substrate, P450 1A1 also exhibited the highest turnover numbers for the formation of tetrols, the hydrolysis products of the diolepoxides, whereas P450 1A2, 2C8, 2C19 and 3A4 showed moderate activities. In order to test the validity of the yeast system, the contribution of each P450 isoform to B[a]P and 7,8-diol metabolism was evaluated as the product of the turnover numbers of recombinant P450s by specific contents of each P450 in human liver microsomes. Calculated formation rates for each B[a]P and 7,8-diol metabolite globally matched experimental values. There is evidence that P450 3A4 and 2C9 play a major role in the formation of 3-hydroxy-B[a]P from B[a]P. Accumulation of the proximate mutagen 7,8-diol was predicted to be mainly driven by P450 1A2, 2C9 and 2C19, while formation of the genotoxic diolepoxides from 7,8-diol appeared to be dependent on P450 1A2 and 3A4 in the liver.

Citing Articles

Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Rendic S, Guengerich F Arch Toxicol. 2021; 95(2):395-472.

PMID: 33459808 PMC: 7880545. DOI: 10.1007/s00204-020-02971-4.


Cytochrome P450 Monooxygenase-Mediated Metabolic Utilization of Benzo[]Pyrene by Species.

Ostrem Loss E, Lee M, Wu M, Martien J, Chen W, Amador-Noguez D mBio. 2019; 10(3).

PMID: 31138742 PMC: 6538779. DOI: 10.1128/mBio.00558-19.


Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Rendic S, Guengerich F Curr Drug Metab. 2017; 19(1):3-46.

PMID: 29219051 PMC: 5886801. DOI: 10.2174/1389200219666171207123939.


Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[]pyrene in prokaryotic and eukaryotic expression systems.

Stiborova M, Indra R, Moserova M, Borek-Dohalska L, Hodek P, Frei E Monatsh Chem. 2017; 148(11):1959-1969.

PMID: 29104317 PMC: 5653725. DOI: 10.1007/s00706-017-2002-0.


Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome.

Yadav S, Seth S, Khan A, Maurya S, Dhawan A, Pant S Appl Transl Genom. 2016; 3(1):8-13.

PMID: 27275407 PMC: 4881805. DOI: 10.1016/j.atg.2013.07.002.